BeT inhibitors in ongoing early-phase clinical trials for hematologic... | Download Table
BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model
Resistance to BET Inhibitor Leads to Alternative Therapeutic Vulnerabilities in Castration-Resistant Prostate Cancer - ScienceDirect
Predicting response to BET inhibitors using computational modeling: A BEAT AML project study - ScienceDirect
Frontiers | Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML | Oncogene
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
JQ1 reduces proliferation and survival of glioblastoma stem cells and... | Download Scientific Diagram
BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc | Cell Death & Disease
BET inhibitors: a novel epigenetic approach - Annals of Oncology
Discovery and characterization of bromodomain 2–specific inhibitors of BRDT | PNAS
Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction | Nature Communications
Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation - ScienceDirect
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours | British Journal of Cancer
JQ1 - Wikipedia
JQ1 treatment of human luminal breast cancer cell lines reduces cell... | Download Scientific Diagram
Cancers | Free Full-Text | The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer | HTML
JQ1 inhibits the proliferation, migration, and invasion of gastric... | Download Scientific Diagram
Frontiers | The BET Inhibitor JQ1 Potentiates the Anticlonogenic Effect of Radiation in Pancreatic Cancer Cells
The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner | Bentham Science
Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4 | Oncogenesis
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy | Future Science OA
Achieving clinical success with BET inhibitors as anti-cancer agents | British Journal of Cancer
Bromodomain inhibitors in clinical trials | Download Table
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer | Scientific Reports
Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases - Kulikowski - 2021 - Medicinal Research Reviews - Wiley Online Library
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
